用cBioPortal中的治疗建议构建变量注释的知识库
Dominik Boehm1,2, Niklas Reimer3,4, Jan Christoph5
1Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Studies in health technology and informatics
|May 17, 2025
概括
分子瘤委员会面临数据收集的挑战,阻碍了个性化治疗讨论. 与MTB-cBioPortal集成的新数字工具简化了对历史治疗建议和结果的访问,提高了效率.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 基因组学就是基因组学.
背景情况:
- 分子瘤板 (MTB) 需要广泛的数据收集来准备病例,这是一个耗时的过程.
- 这种数据瓶限制了讨论的病例数量,可能会推迟患者的个性化治疗.
- 数字支持对于有效管理患者基因组和临床数据至关重要.
研究的目的:
- 开发一个数字解决方案,以简化分子瘤板的病例准备.
- 提高获取类似分子形状的历史治疗建议和后续数据的效率.
- 为治疗策略和结果的多中心数据交换奠定基础.
主要方法:
- 与临床医生合作开发了MTB-cBioPortal的扩展.
- 来自医疗信息化倡议 (MII) 的集成HL7FHIR配置文件和模块.
- 显示历史治疗建议和随访数据作为MTB-cBioPortal患者视图中的注释.
主要成果:
- 开发的扩展为MTB-cBioPortal中的相关患者历史数据提供了有效的访问.
- 用户现在可以查看与分子相似的瘤相关的先前记录的治疗建议.
- 该工具有助于提高分子瘤板的病例准备效率.
结论:
- MTB-cBioPortal扩展可以提高分子瘤板病例准备的效率.
- 这种数字支持系统有助于利用全面的患者数据进行个性化医疗.
- 开发的框架支持未来的多中心合作和数据共享,用于瘤治疗策略.
相关概念视频
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Genome Annotation and Assembly
The genome refers to all of the genetic material in an organism. It can range from a few million base pairs in microbial cells to several billion base pairs in many eukaryotic organisms. Genome assembly refers to the process of taking the DNA sequencing data and putting it all back together in a correct order to create a close representation of the original genome. This is followed by the identification of functional elements on the newly assembled genome, a process called genome annotation.
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


